Barclays’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.83M Sell
56,889
-100,735
-64% -$3.58M ﹤0.01% 2408
2025
Q4
$5.68M Sell
157,624
-2,224
-1% -$81.7K ﹤0.01% 2118
2025
Q3
$5.03M Sell
159,848
-914
-0.6% -$32.8K ﹤0.01% 2191
2025
Q2
$6.84M Buy
160,762
+67,259
+72% +$2.8M ﹤0.01% 1850
2025
Q1
$4.17M Sell
93,503
-16,543
-15% -$890K ﹤0.01% 2055
2024
Q4
$6.04M Sell
110,046
-1,481
-1% -$75K ﹤0.01% 1983
2024
Q3
$4.71M Buy
111,527
+66,082
+145% +$3.14M ﹤0.01% 2150
2024
Q2
$2.09M Sell
45,445
-17,748
-28% -$837K ﹤0.01% 2108
2024
Q1
$3.29M Sell
63,193
-63,417
-50% -$2.78M ﹤0.01% 2152
2023
Q4
$4.51M Buy
126,610
+126,398
+59,622% +$4.4M ﹤0.01% 2187
2023
Q3
$7.11K Sell
212
-26,608
-99% -$923K ﹤0.01% 4348
2023
Q2
$1.01M Buy
26,820
+26,760
+44,600% +$880K ﹤0.01% 2296
2023
Q1
$1.76K Buy
+60
New +$1.74K ﹤0.01% 4899
2022
Q4
Sell
-99,294
Closed -$2.3M 5384
2022
Q3
$2.3M Buy
99,294
+84,618
+577% +$2.31M ﹤0.01% 1652
2022
Q2
$370K Sell
14,676
-23,023
-61% -$680K ﹤0.01% 3067
2022
Q1
$1.44M Sell
37,699
-23,790
-39% -$858K ﹤0.01% 2132
2021
Q4
$2.42M Sell
61,489
-753
-1% -$33K ﹤0.01% 2256
2021
Q3
$3.04M Buy
62,242
+17,323
+39% +$897K ﹤0.01% 2011
2021
Q2
$2.36M Sell
44,919
-45,834
-51% -$2.61M ﹤0.01% 2082
2021
Q1
$5.04M Buy
90,753
+18,825
+26% +$852K ﹤0.01% 1510
2020
Q4
$2.22M Sell
71,928
-37,477
-34% -$892K ﹤0.01% 2155
2020
Q3
$2.03M Buy
109,405
+78,455
+253% +$1.3M ﹤0.01% 2088
2020
Q2
$427K Buy
30,950
+12,135
+64% +$164K ﹤0.01% 3463
2020
Q1
$172K Sell
18,815
-28,079
-60% -$421K ﹤0.01% 4421
2019
Q4
$817K Buy
46,894
+23,715
+102% +$404K ﹤0.01% 3856
2019
Q3
$351K Sell
23,179
-23,785
-51% -$416K ﹤0.01% 4532
2019
Q2
$888K Buy
46,964
+1,281
+3% +$21.8K ﹤0.01% 3807
2019
Q1
$800K Buy
45,683
+44,214
+3,010% +$809K ﹤0.01% 3654
2018
Q4
$26K Sell
1,469
-16,586
-92% -$248K ﹤0.01% 5785
2018
Q3
$255K Sell
18,055
-3,717
-17% -$43.6K ﹤0.01% 4809
2018
Q2
$211K Sell
21,772
-51,838
-70% -$646K ﹤0.01% 4681
2018
Q1
$733K Buy
73,610
+24,519
+50% +$203K ﹤0.01% 3564
2017
Q4
$268K Buy
49,091
+44,262
+917% +$204K ﹤0.01% 4438
2017
Q3
$29K Buy
+4,829
New +$18.5K ﹤0.01% 5630
2015
Q1
Sell
-1,250
Closed -$4K 7274
2014
Q4
$4K Hold
1,250
﹤0.01% 7023
2014
Q3
$3K Hold
1,250
﹤0.01% 7336
2014
Q2
$5K Hold
1,250
﹤0.01% 7128
2014
Q1
$5K Hold
1,250
﹤0.01% 7215
2013
Q4
$4K Hold
1,250
﹤0.01% 7229
2013
Q3
$0 Buy
+1,250
New +$8.93K ﹤0.01% 7631

Other funds holding VCEL

Barclays's VCEL Position: Q1 2026 in Review

Barclays reduced its Vericel Corp (VCEL) stake by 64% in Q1 2026, selling an estimated $3.58M and leaving 56,889 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2408.

Barclays first reported a position in VCEL in Q3 2013 and has held it in 40 quarters since. The position peaked at $6.84M in Q2 2025. 279 funds tracked by Wall St. Rank hold VCEL as of Q1 2026.

  • Barclays held 56,889 shares of Vericel Corp worth $1.83M as of Q1 2026.
  • Barclays sold 100,735 Vericel Corp shares in Q1 2026, an estimated $3.58M.
  • Vericel Corp made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2408 holding.
  • Barclays first reported a position in Vericel Corp in Q3 2013 and has held it in 40 quarters since.
  • Barclays's Vericel Corp position peaked at $6.84M in Q2 2025.
  • 279 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.